Medicines like Paxlovid exist to treat COVID in high-risk people by preventing the virus from multiplying if taken at the ...

UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...

An international clinical trial has identified a medication that can help prevent symptomatic COVID-19 in people exposed ...

An alternative to Paxlovid, the only antiviral pills approved by the US Food and Drug Administration to treat COVID-19, is on ...

The New Normal Five years ago, COVID-19 was declared a global pandemic, marking the official onset of a healthcare crisis that has claimed more than seven ...

A September 2024 article in the journal Biomedicines reviewing the findings of clinical trials for ivermectin and chloroquine ...

A drug called ensitrelvir can help prevent Covid-19 in people who have been exposed within households. This finding comes from an international clinical trial a UVA School of Medicine professor helped ...

Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

The updated mRNA-1273.815 COVID-19 vaccine was significantly protective against hospitalization and medically attended outcomes among adults in the United States.

We’ve learned a lot about COVID-19 over the last five years, but big questions remain. Recent federal actions may hinder the disease’s management.

ADHD prescriptions in England have surged 18% annually since the pandemic, highlighting a major shift in diagnosis and ...

Incorporating systems thinking into drug value assessment promises more realistic evaluations of the impact of new therapies, ...